ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2026
Who receives DXA in VHA direct care vs. community care? Insights into bone health care for veterans.
Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Veterans who choose to receive bone densitometry from a community clinic had less travel burden but may have experienced a longer time from referral to DXA. Ensuring access to DXA for accurate, timely diagnosis and to guide osteoporosis screening remains an important priority. PURPOSE: The Veterans Access, Choice, and Accountability Act (2014) expanded access to community-based dual-energy X-ray absorptiometry (DXA) for eligible veterans facing substantial travel burden or delays in VA access. We examined differences in travel burden, time from referral to DXA, and sociodemographic factors associated with receipt of VA-based DXA (VA-DXA) versus community DXA (CC-DXA) to understand the impact of this policy on veteran access to care.
methodsWe used mixed-effects logistic regression to estimate odds of receiving VA-DXA versus CC-DXA, from October 1, 2019-July 1, 2023, adjusting for clinical and demographic factors related to osteoporosis and access barriers.
resultsFor veterans living < 40 miles from a VA DXA site, CC-DXA recipients traveled shorter distances than VA-DXA recipients (median 6.6 vs. 13.8 miles); this difference widened for those > 40 miles away from a VHA facility (7.0 vs. 60.7 miles). Conversely, VA-DXA had shorter elapsed time from referral to DXA regardless of proximity (e.g., < 40 miles: 24 vs. 39 days from referral). In adjusted models, living > 40 miles from a tertiary VA facility was the strongest predictor of CC-DXA (aOR 4.86). CC-DXA use was more likely among female (aOR 1.60) and rural veterans (aOR 2.01) and among those with low/moderate frailty, and less likely among Black (aOR 0.50) and Asian veterans (aOR 0.57) compared with White veterans, and among Hispanic versus non-Hispanic veterans (aOR 0.84).
conclusionsCC-DXA reduced travel burden but was associated with longer referral-to-DXA time. Ongoing monitoring is warranted to ensure equitable, timely DXA access.
Indexed as
Identifiers
42012636What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.